The role of metronomic chemotherapy in the era of cancer immunotherapy: an oncologist's perspective.
作者信息
Tsao S Y
机构信息
Hong Kong Special Administrative Region Cancer Centre, Hong Kong SAR, P.R.C.
出版信息
Curr Oncol. 2019 Aug;26(4):e422-e424. doi: 10.3747/co.26.4853. Epub 2019 Aug 1.
Abstract
摘要
相似文献
1
The role of metronomic chemotherapy in the era of cancer immunotherapy: an oncologist's perspective.节拍化疗在癌症免疫治疗时代的作用：肿瘤学家的观点。
Curr Oncol. 2019 Aug;26(4):e422-e424. doi: 10.3747/co.26.4853. Epub 2019 Aug 1.
2
Combinatorial immunotherapy strategies: most gods throw dice, but fate plays chess.组合免疫治疗策略：多数神明掷骰子，然命运弈棋局。
Ann Oncol. 2019 Nov 1;30(11):1690-1691. doi: 10.1093/annonc/mdz297.
3
Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.帕妥珠单抗和曲妥珠单抗联合或不联合节拍化疗治疗人表皮生长因子受体 2（HER2）阳性转移性乳腺癌老年患者（EORTC 75111-10114）：老年特别工作组/乳腺癌研究组的一项开放标签、随机、2 期试验。
Lancet Oncol. 2018 Mar;19(3):323-336. doi: 10.1016/S1470-2045(18)30083-4. Epub 2018 Feb 9.
4
Metronomic chemotherapy and immunotherapy in cancer treatment.节拍化疗与免疫治疗在癌症治疗中的应用
Cancer Lett. 2017 Aug 1;400:282-292. doi: 10.1016/j.canlet.2017.01.040. Epub 2017 Feb 9.
5
Oncolytic immunotherapy: an emerging new modality for the treatment of cancer.溶瘤免疫疗法：一种新兴的癌症治疗新模式。
Ann Oncol. 2016 Sep;27(9):1805-8. doi: 10.1093/annonc/mdw194. Epub 2016 May 10.
6
Immunotherapy in colorectal cancer.结直肠癌的免疫治疗
Clin Adv Hematol Oncol. 2018 Jan;16(1):22-24.
7
On OX40 and PD-1 Combination: Why Should OX40 Be First in Sequence?OX40 和 PD-1 联合治疗：为什么 OX40 应优先使用？
Clin Cancer Res. 2017 Oct 15;23(20):5999-6001. doi: 10.1158/1078-0432.CCR-17-2332.
8
Immune checkpoint inhibitors: The linchpins of modern immunotherapy.免疫检查点抑制剂：现代免疫疗法的关键。
Immunol Rev. 2019 Jul;290(1):6-23. doi: 10.1111/imr.12766.
9
Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy.社论：免疫检查点分子与癌症免疫疗法
Front Immunol. 2018 Dec 5;9:2878. doi: 10.3389/fimmu.2018.02878. eCollection 2018.
10
[Cancer immunotherapy].[癌症免疫疗法]
Ugeskr Laeger. 2018 May 21;180(21).
引用本文的文献
1
Perspectives of traditional Chinese medicine to patch up immune checkpoint blockers.中医对补充免疫检查点阻断剂的见解。
Explor Target Antitumor Ther. 2022;3(5):676-693. doi: 10.37349/etat.2022.00107. Epub 2022 Oct 31.
2
Potential of mRNA vaccines to become versatile cancer vaccines.信使核糖核酸疫苗成为通用癌症疫苗的潜力。
World J Clin Oncol. 2022 Aug 24;13(8):663-674. doi: 10.5306/wjco.v13.i8.663.
3
Embracing cancer immunotherapy with vital micronutrients.用关键微量营养素接受癌症免疫疗法。
World J Clin Oncol. 2021 Sep 24;12(9):712-724. doi: 10.5306/wjco.v12.i9.712.
4
Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer.在原发性原位和转移性小鼠乳腺癌中评估免疫刺激和抗肿瘤节拍性环磷酰胺方案。
NPJ Breast Cancer. 2020 Jul 20;6:29. doi: 10.1038/s41523-020-0171-1. eCollection 2020.
本文引用的文献
1
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma.转移性透明细胞肾细胞癌一线治疗的现有和新兴疗法。
Cancer Treat Rev. 2018 Nov;70:127-137. doi: 10.1016/j.ctrv.2018.07.009. Epub 2018 Jul 20.
2
Regulatory T cells: a potential target in cancer immunotherapy.调节性 T 细胞：癌症免疫治疗的一个潜在靶点。
Ann N Y Acad Sci. 2018 Apr;1417(1):104-115. doi: 10.1111/nyas.13625. Epub 2018 Mar 22.
3
Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.免疫化疗：剂量和方案依赖性以及与免疫疗法的联合应用。
Cancer Lett. 2018 Apr 10;419:210-221. doi: 10.1016/j.canlet.2018.01.050.
4
Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?三阴性转移性乳腺癌中的节拍化疗：未来已来？
Int J Breast Cancer. 2017;2017:1683060. doi: 10.1155/2017/1683060. Epub 2017 Dec 3.
5
A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells.免疫检查点抑制联合节拍化疗靶向治疗耐药癌细胞。
Int J Mol Sci. 2017 Oct 13;18(10):2134. doi: 10.3390/ijms18102134.
6
EGFR TKI combination with immunotherapy in non-small cell lung cancer.表皮生长因子受体酪氨酸激酶抑制剂与免疫疗法联合用于非小细胞肺癌的治疗
Expert Opin Drug Saf. 2017 Apr;16(4):465-469. doi: 10.1080/14740338.2017.1300656. Epub 2017 Mar 8.
7
Regulatory T cells in cancer immunotherapy.癌症免疫治疗中的调节性T细胞。
Cell Res. 2017 Jan;27(1):109-118. doi: 10.1038/cr.2016.151. Epub 2016 Dec 20.
8
Immunogenic cell death in cancer and infectious disease.肿瘤和传染病中的免疫原性细胞死亡
Nat Rev Immunol. 2017 Feb;17(2):97-111. doi: 10.1038/nri.2016.107. Epub 2016 Oct 17.
9
Efficacy and safety of vinorelbine-capecitabine oral metronomic combination in elderly metastatic breast cancer patients: VICTOR-1 study.长春瑞滨-卡培他滨口服节拍联合疗法在老年转移性乳腺癌患者中的疗效与安全性：VICTOR-1研究
Tumori. 2017 Jan 21;103(1):e4-e8. doi: 10.5301/tj.5000543.
10
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer.环磷酰胺与口服聚（ADP-核糖）聚合酶抑制剂维利帕尼治疗复发、晚期三阴性乳腺癌患者的随机II期试验
Invest New Drugs. 2016 Jun;34(3):355-63. doi: 10.1007/s10637-016-0335-x. Epub 2016 Mar 21.
Zotero 插件